Kommoss F - Search Results

1

Ovarian endometrioid-like yolk sac tumor treated by surgery alone, with recurrence at 12 years.

Kommoss F, Schmidt M, Merz E, Knapstein PG, Young RH, Scully RE. Kommoss F, et al. Gynecol Oncol. 1999 Mar;72(3):421-4. doi: 10.1006/gyno.1998.5256. Gynecol Oncol. 1999. PMID: 10053117

2

Inhibin-alpha CD99, HEA125, PLAP, and chromogranin immunoreactivity in testicular neoplasms and the androgen insensitivity syndrome.

Kommoss F, Oliva E, Bittinger F, Kirkpatrick CJ, Amin MB, Bhan AK, Young RH, Scully RE. Kommoss F, et al. Hum Pathol. 2000 Sep;31(9):1055-61. doi: 10.1053/hupa.2000.16237. Hum Pathol. 2000. PMID: 11014571

3

Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study.

Kommoss F, Oliva E, Bhan AK, Young RH, Scully RE. Kommoss F, et al. Mod Pathol. 1998 Jul;11(7):656-64. Mod Pathol. 1998. PMID: 9688187

4

Fertility-sparing surgery and reproductive-outcomes in patients with borderline ovarian tumors.

Plett H, Harter P, Ataseven B, Heitz F, Prader S, Schneider S, Heikaus S, Fisseler-Eckhoff A, Kommoss F, Lax SF, Staebler A, Traut A, du Bois A. Plett H, et al. Among authors: kommoss f. Gynecol Oncol. 2020 May;157(2):411-417. doi: 10.1016/j.ygyno.2020.02.007. Epub 2020 Feb 27. Gynecol Oncol. 2020. PMID: 32115229

5

Steroid receptor expression in endometria from women treated with tamoxifen.

Kommoss F, Karck U, Prömpeler H, Pfisterer J, Kirkpatrick CJ. Kommoss F, et al. Gynecol Oncol. 1998 Aug;70(2):188-91. doi: 10.1006/gyno.1998.5087. Gynecol Oncol. 1998. PMID: 9740688

6

Survival benefit for patients with advanced-stage transitional cell carcinomas vs. other subtypes of ovarian carcinoma after chemotherapy with platinum and paclitaxel.

Kommoss F, Kommoss S, Schmidt D, Trunk MJ, Pfisterer J, du Bois A; Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom. Kommoss F, et al. Among authors: kommoss s. Gynecol Oncol. 2005 Apr;97(1):195-9. doi: 10.1016/j.ygyno.2004.12.047. Gynecol Oncol. 2005. PMID: 15790458 Clinical Trial.

7

Recurrent cytogenetic aberrations and loss of constitutional heterozygosity in ovarian carcinomas.

Kiechle-Schwarz M, Bauknecht T, Karck U, Kommoss F, du Bois A, Pfleiderer A. Kiechle-Schwarz M, et al. Among authors: kommoss f. Gynecol Oncol. 1994 Nov;55(2):198-205. doi: 10.1006/gyno.1994.1277. Gynecol Oncol. 1994. PMID: 7959284

8

Chemotherapy may be more effective in highly proliferative ovarian carcinomas--a translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol).

Kommoss S, du Bois A, Schmidt D, Parwaresch R, Pfisterer J, Kommoss F. Kommoss S, et al. Among authors: kommoss f. Gynecol Oncol. 2006 Oct;103(1):67-71. doi: 10.1016/j.ygyno.2006.01.037. Epub 2006 Mar 3. Gynecol Oncol. 2006. PMID: 16516280

9

Steroid receptors in ovarian carcinoma: immunohistochemical determination may lead to new aspects.

Kommoss F, Pfisterer J, Thome M, Schäfer W, Sauerbrei W, Pfleiderer A. Kommoss F, et al. Gynecol Oncol. 1992 Dec;47(3):317-22. doi: 10.1016/0090-8258(92)90133-4. Gynecol Oncol. 1992. PMID: 1473744

10

Human papillomavirus DNA in distant metastases of cervical cancer.

Ikenberg H, Teufel G, Schmitt B, Kommoss F, Stanimirovic B, Pfleiderer A. Ikenberg H, et al. Among authors: kommoss f. Gynecol Oncol. 1993 Jan;48(1):56-60. doi: 10.1006/gyno.1993.1009. Gynecol Oncol. 1993. PMID: 8380788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters